130 related articles for article (PubMed ID: 10597047)
21. Childhood leukemia genetic bottleneck phenomenon related to TEL-AML1: the postulation by a mathematical model.
Ivanovski P; Ivanovski I; Nikolić D; Jovanović I
Chin Med J (Engl); 2012 Mar; 125(6):1182-5. PubMed ID: 22613552
[TBL] [Abstract][Full Text] [Related]
22. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia.
Pine SR; Wiemels JL; Jayabose S; Sandoval C
Leuk Res; 2003 Feb; 27(2):155-64. PubMed ID: 12526921
[TBL] [Abstract][Full Text] [Related]
23. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
Erickson PF; Dessev G; Lasher RS; Philips G; Robinson M; Drabkin HA
Blood; 1996 Sep; 88(5):1813-23. PubMed ID: 8781439
[TBL] [Abstract][Full Text] [Related]
24. Detection of the Der (21)t(12;21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia.
Kobayashi H; Satake N; Kaneko Y
Leuk Lymphoma; 1997 Dec; 28(1-2):43-50. PubMed ID: 9498702
[TBL] [Abstract][Full Text] [Related]
25. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
Peter A; Heiden T; Taube T; Körner G; Seeger K
Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
[TBL] [Abstract][Full Text] [Related]
26. A distinct epigenetic signature at targets of a leukemia protein.
Rossetti S; Hoogeveen AT; Liang P; Stanciu C; van der Spek P; Sacchi N
BMC Genomics; 2007 Feb; 8():38. PubMed ID: 17266773
[TBL] [Abstract][Full Text] [Related]
27. Low frequency of the TEL/AML1 fusion gene in acute lymphoblastic leukaemia in Spain.
García-Sanz R; Alaejos I; Orfão A; Rasillo A; Chillón MC; Tabernero MD; Mateos MV; López-Pérez R; González D; Balanzategui A; González M; San Miguel JF; Bortolucci A
Br J Haematol; 1999 Dec; 107(3):667-9. PubMed ID: 10583273
[TBL] [Abstract][Full Text] [Related]
28. Lack of TEL-AML1 fusion transcript resulting from a cryptic t(12;21) in adult B lineage acute lymphoblastic leukemia in Taiwan.
Shih LY; Chou TB; Liang DC; Tzeng YS; Rubnitz JE; Downing JR; Pui CH
Leukemia; 1996 Sep; 10(9):1456-8. PubMed ID: 8751462
[TBL] [Abstract][Full Text] [Related]
29. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion.
Romana SP; Mauchauffé M; Le Coniat M; Chumakov I; Le Paslier D; Berger R; Bernard OA
Blood; 1995 Jun; 85(12):3662-70. PubMed ID: 7780150
[TBL] [Abstract][Full Text] [Related]
30. TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.
Ramakers-van Woerden NL; Pieters R; Loonen AH; Hubeek I; van Drunen E; Beverloo HB; Slater RM; Harbott J; Seyfarth J; van Wering ER; Hählen K; Schmiegelow K; Janka-Schaub GE; Veerman AJ
Blood; 2000 Aug; 96(3):1094-9. PubMed ID: 10910927
[TBL] [Abstract][Full Text] [Related]
31. Chemosensitivity of TEL-AML1 fusion transcript positive acute lymphoblastic leukemia cells.
Krishna Narla R; Navara C; Sarquis M; Uckun FM
Leuk Lymphoma; 2001 May; 41(5-6):615-23. PubMed ID: 11378579
[TBL] [Abstract][Full Text] [Related]
32. The majority of myeloid-antigen-positive (My+) childhood B-cell precursor acute lymphoblastic leukaemias express TEL-AML1 fusion transcripts.
Baruchel A; Cayuela JM; Ballerini P; Landman-Parker J; Cezard V; Firat H; Haddad E; Auclerc MF; Valensi F; Cayre YE; Macintyre EA; Sigaux F
Br J Haematol; 1997 Oct; 99(1):101-6. PubMed ID: 9359509
[TBL] [Abstract][Full Text] [Related]
33. Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis.
Attarbaschi A; Mann G; König M; Dworzak MN; Trebo MM; Mühlegger N; Gadner H; Haas OA;
Leukemia; 2004 Oct; 18(10):1611-6. PubMed ID: 15356655
[TBL] [Abstract][Full Text] [Related]
34. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
[TBL] [Abstract][Full Text] [Related]
35. Genetic abnormalities involved in t(12;21) TEL-AML1 acute lymphoblastic leukemia: analysis by means of array-based comparative genomic hybridization.
Tsuzuki S; Karnan S; Horibe K; Matsumoto K; Kato K; Inukai T; Goi K; Sugita K; Nakazawa S; Kasugai Y; Ueda R; Seto M
Cancer Sci; 2007 May; 98(5):698-706. PubMed ID: 17374122
[TBL] [Abstract][Full Text] [Related]
36. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice.
Bernardin F; Yang Y; Cleaves R; Zahurak M; Cheng L; Civin CI; Friedman AD
Cancer Res; 2002 Jul; 62(14):3904-8. PubMed ID: 12124316
[TBL] [Abstract][Full Text] [Related]
37. The AML1/ETO fusion protein activates transcription of BCL-2.
Klampfer L; Zhang J; Zelenetz AO; Uchida H; Nimer SD
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14059-64. PubMed ID: 8943060
[TBL] [Abstract][Full Text] [Related]
38. TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression.
Asakura K; Uchida H; Miyachi H; Kobayashi H; Miyakawa Y; Nimer SD; Takahashi H; Ikeda Y; Kizaki M
Mol Cancer Res; 2004 Jun; 2(6):339-47. PubMed ID: 15235109
[TBL] [Abstract][Full Text] [Related]
39. AML1 interconnected pathways of leukemogenesis.
Michaud J; Scott HS; Escher R
Cancer Invest; 2003; 21(1):105-36. PubMed ID: 12643014
[TBL] [Abstract][Full Text] [Related]
40. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model.
Fischer M; Schwieger M; Horn S; Niebuhr B; Ford A; Roscher S; Bergholz U; Greaves M; Löhler J; Stocking C
Oncogene; 2005 Nov; 24(51):7579-91. PubMed ID: 16044150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
